Remove tag virtual-care
article thumbnail

Grand Rounds July 7, 2023: Implementing Virtual Strategies Across an Integrated Healthcare System: The IMPLEMENT-HF Study (Ankeet S. Bhatt, MD, MBA, ScM)

Rethinking Clinical Trials

There is renewed interest in implementation science in cardiometabolic care to better understand optimal pathways for delivering these therapies in patients with HFrEF. They made only one suggestion a day for how to optimize the patient’s care, such as initiation of one therapy or an up titration of an existent therapy.

article thumbnail

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

GGC4H is a 5-year, longitudinal cluster-randomized trial that took place in pediatric primary care. The study offered GGC to all caregivers in the intervention arm, using 2 modalities, virtual groups and digital self-guided. GG4CH conducted 4 studies asking 1) Do caregivers want virtual parenting support?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

New technologies are being developed that allow for virtual clinical trials and other cost-lowering development costs. Hospitals receive $1 out of every $3 spent on health care, and the United States is projected to spend about $1.3 trillion for hospital care alone in 2019. healthcare spending will reach $6.2

Drugs 222
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

Consider secure digital identification, two-fact authentication or virtual/video visits. The skills may also vary between trials and getting participants the care they need. In a remote study, it would be possible for duplicate enrollment, falsified or fabricated eligibility source documents, or data completed by surrogates.

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. It also develops services to support the evolution of medical care and finding purposes in life, in collaboration with various research institutions and companies.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

We had an opportunity to meet once, and then everything became virtual. We wanted to make sure we were encouraging flexibility of design and use of technology, while still highlighting what people need to be careful with. I think collectively, we want to promote the utilization of health care in research.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

We had an opportunity to meet once, and then everything became virtual. We wanted to make sure we were encouraging flexibility of design and use of technology, while still highlighting what people need to be careful with. I think collectively, we want to promote the utilization of health care in research.